GlassScriptPhysician profile
Ronald D Richmond
NPI 1255337713
$1,734.96
in general payments reported to CMS, 2019-2025
20 companies · $40.30 in 2025
The $40.30 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $622 · 2020: $82.06 · 2021: $147 · 2022: $706 · 2023: $69.81 · 2024: $67.82 · 2025: $40.30.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $178.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $177.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $401.12 | 2019-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $261.73 | 2022-2023 | |
| Abbvie INC. | $217.70 | 2021-2025 | |
| Glaxosmithkline, LLC. | $211.16 | 2019-2022 | |
| Exact Sciences Corporation | $87.88 | 2024-2025 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $79.51 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $76.88 | 2022 | |
| Astellas Pharma US INC | $68.31 | 2019 | |
| Pfizer INC. | $65.78 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $48.98 | 2019-2022 | |
| Novo Nordisk INC | $35.64 | 2019-2022 | |
| Alnylam Pharmaceuticals INC. | $29.46 | 2023 | Givlaari |
| Boston Scientific Corporation | $28.98 | 2019 | |
| Amgen INC. | $28.63 | 2019 | |
| Neurocrine Biosciences, INC. | $27.27 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Antares Pharma, INC. | $15.28 | 2019 | |
| Janssen Pharmaceuticals, INC | $14.67 | 2022 | |
| Sanofi Pasteur INC. | $13.01 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $11.61 | 2019 | |
| Therapeuticsmd, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Richmond listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.